Business Context and Reporting Period
Company: Organogenesis Holdings Inc.
Filing Type: Form 8-K (Current Report)
Report Date: November 6, 2025
Reporting Period: Fiscal Third Quarter ended September 30, 2025
This filing serves as a notification that the Company announced its financial results for the third quarter of 2025 via a press release. The detailed financial data is contained within the press release attached as Exhibit 99.1, which is incorporated by reference but explicitly stated as "furnished" rather than "filed" for liability purposes under Section 18 of the Exchange Act.
Key Financial Metrics
The provided text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being available in the attached press release (Exhibit 99.1) but are not present in the body of this 8-K summary.
Material Changes
No material changes versus the prior comparable period are detailed in the text of this filing. The document solely announces the release of the third-quarter results.
Guidance, Outlook, and Risks
Management Commentary: The filing indicates that management has issued a press release regarding the third-quarter results, but no specific commentary, guidance, or outlook is included in the 8-K text itself.
Risks and Contingencies: No specific risks or contingencies are disclosed in this excerpt. The filing notes the standard legal disclaimer that the attached press release is not deemed "filed" for liability purposes under Section 18 of the Exchange Act.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 6, 2025) for actual revenue, net income, and cash flow figures.
- Verify the specific year-over-year and quarter-over-quarter performance metrics not listed in this summary.
- Check for any forward-looking statements or updated guidance included in the full press release.
- Confirm the status of the "furnished" vs. "filed" designation for the press release content regarding liability.